Agenda of the workshop on the impact of reference measurement systems on clinical evidence on 04 December 2013

Welcome and introduction to JCTLM Stakeholders meetings

M. Muller

Introduction to Clinical Evidence and measurements

P. Bossuyt

Case study 1: Creatinine and Chronic Kidney Disease

G. Jones

Case study 2: HbA1c and Diabetes

P. Gillery

Case study 3: PSA ; Standardization and variability comparative study in hospitals

O. Blake

Case study 4: Free Thyroxine ; Reference Measurement Systems for FT4

L. Thienpont

Agenda of the Workshop on Commutability on 04 December 2013

An introduction and challenges related to Commutability

G. Miller

Commutability and traceability: an IVD Industry View1

D. Armbruster

Comutability issues for EQA Scheme Organizer

L. Siekmann

Improving definitions and dealing with commutability

D. Stockl

Assessing the commutability of WHO International Standards

C. Burns

Outcomes of WHO consultation on commutability

D. Wood

Commutability Studies undertaken by the IRMM

I. Zegers

Commutability studies undertaken by the NIST

K. Phinney

Commutability studies undertaken by the LNE

V. Delatour